NEW TYROSINE KINASE INHIBITORS FOR ONCOLOGICAL AND IMMUNOLOGICAL USE FROM A MEDICINAL CHEMISTRY PERSPECTIVE

Abstract

A documentary review was carried out on the production and publication of research papers related to the study of the variable Tyrosine Kinase and Oncology. The purpose of the bibliometric analysis proposed in this document is to know the main characteristics of the volume of publications registered in Scopus database during the period between 2016 and 2021, achieving the identification of 739 publications. The information provided by said platform was organized by means of tables and figures categorizing the information by Year of Publication, Country of Origin, Area of Knowledge and Type of Publication. Once these characteristics were described, the position of different authors regarding the proposed topic was referenced by means of a qualitative analysis. Among the main findings of this research, it is found that Brazil, with 368 publications, was the country with the highest production in the Latin American community. The Area of Knowledge that made the greatest contribution to the construction of bibliographic material referring to the study of the new Tyrosine Kinase Inhibitors and their use in Oncological treatments was the area of Medicine with 495 published documents, and the Type of Publication that was most used during the period indicated above was the Journal Article, which represents 75% of the total scientific production.